stanozolol has been researched along with Left Ventricular Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andresen-Streichert, H; Geyer, H; Glenewinkel, F; Juebner, M; Lehmann, S; Rothschild, MA; Schiwy-Bochat, KH; Thevis, M; Thomas, A | 1 |
| Darke, S; Duflou, J; Torok, M | 1 |
2 other study(ies) available for stanozolol and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone).
Topics: Adult; Anabolic Agents; Androstanols; Clenbuterol; Clomiphene; Coronary Vessels; Doping in Sports; Fatal Outcome; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Methandrostenolone; Stanozolol; Testosterone; Trenbolone Acetate | 2019 |
Sudden or unnatural deaths involving anabolic-androgenic steroids.
Topics: Adult; Anabolic Agents; Androgens; Atrophy; Coronary Stenosis; Epitestosterone; Homicide; Humans; Hypertrophy, Left Ventricular; Male; Methandrostenolone; Middle Aged; Nandrolone; New South Wales; Stanozolol; Substance-Related Disorders; Suicide; Testis; Testosterone; Young Adult | 2014 |